Effectiveness and safety of photobiomodulation therapy in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis
PLOS ONE · 2024
DOI: 10.1371/journal.pone.0308537 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, 2024. Verfasst von Xuechun Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Low-Level Light Therapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine, Jilin Scientific and Technological Development Program.
Abstract (Originalsprache)
Introduction
Diabetic peripheral neuropathy (DPN), a widely prevalent complication in patients with type 2 diabetes, exerts a significant influence on patients’ overall health and financial circumstances. Photobiomodulation therapy is one of the means of physical therapy for DPN. Although preliminary findings suggest the efficacy of photobiomodulation therapy in alleviating peripheral neuropathy, the existing literature lacks substantial evidence regarding its safety and effectiveness specifically in the context of diabetes-related peripheral neuropathy. Therefore, we plan to arrive at more distinct findings through systematic evaluation and meta-analysis.
Methods
We will conduct a comprehensive search for studies published from the beginning until October 1, 2023, using various databases including Web of Science, Embase, Cochrane Library, PubMed, AMED, Wanfang database, VIP database, China National Knowledge Infrastructure, and the Chinese Biomedical Literature database. Simultaneously, we will also search for the WHO International Clinical Trial Registration Platform, China Clinical Trial Registration Platform, and Clinical Trials.gov. Gray literature will be retrieved using Google Scholar and opengrey.edu . Only randomized controlled trials in Chinese and English were included, with no restrictions on publication status. The primary outcomes will include change of symptom scores, change of nerve conduction velocity. Additional outcomes will encompass quality of life, change in pain, blood glucose levels after fasting and 2 hours after eating, levels of glycosylated hemoglobin, and any adverse events associated with photobiomodulation therapy. Reman V.5.4 and R language will be used for the meta-analysis. Assessment of potential bias will be conducted through Cochrane risk of bias 2 tool (RoB 2.0) and Physiotherapy Evidence Database (PEDro) scale. Registration: PROSPERO (registration number: CRD42023466586).
Discussion
This meta-analysis aims to assess the efficacy and safety of photobiomodulation therapy as a potential treatment for diabetic peripheral neuropathy (DPN), and providing a straightforward and convenient therapeutic for patients. Additionally, it expands the range of treatment alternatives available to healthcare professionals managing DPN.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, Changchun, China.
- Department of Endocrinology, First Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, China.
ORCID-Profile: Guanchi Yan, Jia Mi
Förderung
- National Natural Science Foundation of China
- Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
- Jilin Scientific and Technological Development Program
- National Key Research and Development Program of China
- Jilin Province Traditional Chinese Medicine Science and Technology Project
Zitieren
APA
Fan, X., Yan, G., Cao, J., Zhao, Y., Wang, Y., Wang, X., & Mi, J. (2024). Effectiveness and safety of photobiomodulation therapy in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis. PLOS ONE. https://doi.org/10.1371/journal.pone.0308537
Vancouver
Fan X, Yan G, Cao J, Zhao Y, Wang Y, Wang X, et al. Effectiveness and safety of photobiomodulation therapy in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis. PLOS ONE. 2024. doi:10.1371/journal.pone.0308537
BibTeX
@article{Fan2024,
author = {Fan, Xuechun and Yan, Guanchi and Cao, Jingsi and Zhao, Yunyun and Wang, Ying and Wang, Xiuge and Mi, Jia},
title = {Effectiveness and safety of photobiomodulation therapy in diabetic peripheral neuropathy: Protocol for a systematic review and meta-analysis},
journal = {PLOS ONE},
year = {2024},
doi = {10.1371/journal.pone.0308537}
}
EUVIMED